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Developmental arrest in 
Drosophila melanogaster caused 
by mitochondrial DNA replication 
defects cannot be rescued by the 
alternative oxidase
Ana Paula C. Rodrigues1, André F. Camargo1, Ana Andjelković2,3, Howard T. Jacobs2,3 & 
Marcos T. Oliveira1
The xenotopic expression of the alternative oxidase AOX from the tunicate Ciona intestinalis in diverse 
models of human disease partially alleviates the phenotypic effects of mitochondrial respiratory 
chain defects. AOX is a non-proton pumping, mitochondrial inner membrane-bound, single-subunit 
enzyme that can bypass electron transport through the cytochrome segment, providing an additional 
site for ubiquinone reoxidation and oxygen reduction upon respiratory chain overload. We set out 
to investigate whether AOX expression in Drosophila could counteract the effects of mitochondrial 
DNA (mtDNA) replication defects caused by disturbances in the mtDNA helicase or DNA polymerase 
γ. We observed that the developmental arrest imposed by either the expression of mutant forms of 
these enzymes or their knockdown was not rescued by AOX. Considering also the inability of AOX to 
ameliorate the phenotype of tko25t, a fly mutant with mitochondrial translation deficiency, we infer 
that this alternative enzyme may not be applicable to cases of mitochondrial gene expression defects. 
Finding the limitations of AOX applicability will help establish the parameters for the future putative use 
of this enzyme in gene therapies for human mitochondrial diseases.
Mutations in the human genes TWNK and POLG, respectively encoding the mitochondrial replicative DNA 
helicase Twinkle and the catalytic subunit of the mitochondrial replicase pol γ, are associated with diverse human 
diseases, as well as with aging. In particular, they underlie cases of Progressive External Ophthalmoplegia (PEO) 
and Alper’s syndrome, for which mitochondrial DNA (mtDNA) depletion, deletions and/or point mutations 
are frequently observed1–4. Twinkle and pol γ are essential components of the mtDNA replication machinery. 
Twinkle hydrolyzes nucleotide tri-phosphate to unwind the parental double-stranded DNA, providing the 
single-stranded DNA template for pol γ. In concert with the mitochondrial single-stranded DNA-binding protein 
(mtSSB), Twinkle and pol γ, and possibly replisome proteins that remain to be identified, can promote mtDNA 
replication and guarantee proper levels of this genome for correct organellar gene expression5,6. mtDNA carries 
genes that are essential for ATP production via the process of oxidative phosphorylation (OXPHOS).
Mitochondrial diseases exhibit a broad clinical spectrum, often requiring treatments that are specific to each 
type of disorder, with only a few such treatments shown thus far to be convincingly effective7. However, the fact 
that OXPHOS is often affected in mitochondrial diseases does provide a possible common target for therapeutic 
interventions: the respiratory chain (RC). Four of the RC complexes transfer electrons to molecular oxygen, a 
process coupled to energy transduction forming a proton gradient across the mitochondrial inner membrane, 
whereas a fifth complex uses this gradient to phosphorylate ADP to ATP. Most organisms possess branches of 
the electron transfer system known as alternative pathways, which are absent in humans, other vertebrates, and 
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insects8,9. These pathways may represent “safety valves” to alleviate stress arising from RC overload, as is the case 
in mitochondrial diseases, preventing excess formation of reactive oxygen species (ROS) and allowing reoxida-
tion of primary electron carriers such as NADH. The alternative oxidase (AOX), for example, is a single-subunit 
enzyme able to transfer electrons from ubiquinol to oxygen, bypassing RC complexes III and IV, without proton 
pumping. It has been suggested that AOX expression in human mitochondria could be a treatment for patients 
with mitochondrial diseases, as a bypass therapy7,10.
The transgenic expression of the AOX gene from Ciona intestinalis (Tunicata: Ascidiacea) in cultured human 
cells, in the mouse, and in the fruitfly Drosophila melanogaster showed several benefits, which are consistent 
with a role for AOX in buffering OXPHOS stresses, caused by chemical, genetic or physiological damage. It 
promoted resistance to inhibitors of complexes III and IV11–14, alleviated the metabolic abnormalities of com-
plex IV-deficient cells derived from patients15 and the deleterious phenotypes of complex IV insufficiency in 
Drosophila16. AOX function has also been reported to provide some benefit in other models of mitochondrial 
disorders, such as fly lines with knockdown of pol γ17 or with mutations in dj-1β, the homologue of the human 
Parkinson’s disease gene DJ112, and in sesB, the homologue of another PEO gene, ANT118. In addition, the rescue 
by AOX of Drosophila models of Alzheimer’s disease and mid-line closure defects suggests that RC dysfunction 
and/or excess ROS production are not only involved, but also appear in early stages of these pathogeneses19,20.
We set out to investigate if the beneficial effects of AOX expression in higher metazoans is applicable to fly 
lines with mtDNA replication defects. Considering the earlier finding that AOX can ameliorate the phenotype of 
pol γ-depleted flies, which are defective in mtDNA replication, we hypothesized that AOX could have the same 
effect in flies with defects in the Drosophila homologue of Twinkle. Our data shows that AOX does not rescue 
developmental lethality, nor alter the biochemical and molecular parameters associated with Twinkle and pol γ 
mutations or knockdown. This restricts the potential therapeutic use of AOX to specific types of mitochondrial 
dysfunction.
Results
AOX does not rescue lethality caused by Twinkle mutations. Using standard genetic crosses, we 
initially created 12 fly lines, in which we combined the AOX variant constructs UAS-empty2nd, UAS-mutAOX2nd, 
UAS-wtAOX8.1 and UAS-wtAOXF6, with the Twinkle variant constructs UAS-Twinkle WT, UAS-Twinkle K388A, 
and UAS-Twinkle A442P (see Supplementary Table S1). UAS-empty2nd carries the UAS promoter without any 
associated transgene, serving as a promoter dilution control, whereas UAS-mutAOX2nd bears the coding sequence 
for a mutated, inactive form of AOX (mut AOX)21. UAS-wtAOX8.1 and UAS-wtAOXF6, when induced, lead to the 
expression of AOX at low and high levels, respectively12,21. The Twinkle variant constructs guide the respective 
overexpression of the wild-type form of the mtDNA helicase (WT), an active-site mutant (K388A), and a PEO 
mutation-bearing variant (A442P)22. The latter represents a fly mutation homologous to the one found in human 
PEO families, A475P23.
We then crossed the UAS-AOX; UAS-Twinkle lines with the ubiquitous GAL4 driver daGAL4 (see 
Supplementary Fig. S1 for crossing schemes, and Supplementary Fig. S2 for immunoblot detection of the over-
expressed enzymes). Consistent with previously published data22, overexpression of Twinkle WT in the offspring 
did not affect development, whereas almost all flies expressing the K388A and A442P variants died at the larva L3 
or pupal stages (Fig. 1). The lethality of K388A was more severe, as very few larvae were able to enter the pre-pupa 
stage, dying immediately (Fig. 1b); most L3 larvae were apparently fully developed and mobile at day 5 after egg 
laying, but remained in this state for an additional 9 days before perishing. Although a very low percentage of 
adult individuals expressing Twinkle A442P did eclose, indicating that most flies died at the pupa stage, we also 
observed lethality at the larval stage, judged by the ratio between wild-type and Tubby pupae resulting from the 
cross UAS-empty2nd; UAS-Twinkle A442P/TM6B-Tubby X daGAL4 (Fig. 1c and Supplementary Fig. S1), which 
was lower than the expected Mendelian proportion.
Coexpression of AOX with Twinkle variants in different combinations had only minor effects on adult eclo-
sion rates, and AOX did not rescue the larval lethality caused by Twinkle K388A (Fig. 1a,b). Surprisingly, high lev-
els of functional AOX appeared to intensify the larval lethality caused by Twinkle A442P, as no UAS-wtAOXF6/2; 
UAS-Twinkle A442P/daGAL4 larva (see Supplementary Fig. S1) ever developed beyond the pre-pupa stage, 
resembling the more severe K388A phenotype (Fig. 1c). Our data shows that AOX cannot alleviate the develop-
mental disturbances caused by overexpression of Twinkle mutations, and suggests it could in fact aggravate them.
AOX does not alter mtDNA copy number in mutant Twinkle flies. In addition to the expected 
mtDNA depletion caused by the overexpression of the Twinkle mutants22, we hypothesized that mtDNA copy 
number might be affected by AOX, since mtDNA maintenance has been linked to mitochondrial membrane 
potential24 and AOX could potentially lower this parameter by diverting respiratory electron flow. We therefore 
measured relative mtDNA copy number in our fly lines via quantitative PCR, but found that AOX does not sig-
nificantly change mtDNA levels in any Twinkle combination (Fig. 2). Overexpressing Twinkle WT did not alter 
mtDNA copy number in L3 larvae, although a 30–40% increase was observed in adult flies (Fig. 2). Copy number 
increase upon Twinkle WT overexpression has been reported previously for Drosophila adults22 and cells in cul-
ture25, for human cells in culture26 and for mice27,28. As expected, overexpression of Twinkle K388A and A442P 
depleted mtDNA in L3 larvae to 20–40% of control levels, independently of AOX expression.
Developmental effects of Twinkle mutants are tissue-specific. Next, we checked if AOX could 
improve mitochondrial function upon expression of the Twinkle mutants, although it cannot rescue the flies 
from lethality. Surprisingly, none of the Twinkle variants altered mitochondrial oxygen consumption driven by 
complex I or IV substrate oxidation in the body wall tissues of L3 larvae (Fig. 3 and Supplementary Fig. S3). Even 
though there was an increase in respiration in all Twinkle overexpressors in the presence of functional AOX, 
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this was not statistically significant, except in the presence of the complex III inhibitor antimycin A, as expected 
(Fig. 3, middle panel). Because the larval body wall consists mostly of muscular and nervous tissues, we tested if 
tissue-specific expression of the Twinkle mutations using the mhcGAL4 and elavGAL4 drivers, respectively, could 
reproduce the lethal phenotype observed in the presence or absence of AOX. Consistent with the lack of detect-
able OXPHOS dysfunction in the larval body wall, flies overexpressing Twinkle K388A or A442P in muscles or 
neurons completed normal development (Supplementary Fig. S4). Again, coexpression of AOX had no effect on 
the developmental parameters analyzed. In addition to the observation that the L3 larvae expressing K388A and 
A442P via daGAL4 induction appear actively “healthy” for several days after the expected time of pupation, our 
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Figure 1. AOX does not rescue the lethality caused by the expression of mutant Twinkle proteins. (a) Pupal 
viability was measured as the mean ratio between the number of adults eclosed and the number of pupae per 
vial (+/− standard deviation), upon expression (using the daGAL4 driver, left panel) or not (using the w1118 
control, right panel) of the indicated AOX and Twinkle variants. (b) A representative developmental assay 
showing the inability of larvae overexpressing Twinkle K388A to enter the pupal stage: whereas the control 
adult flies at day 7–9 after egg laying (right panel) were starting to eclose, Twinkle K388A flies were still alive 
as active larvae on the food, with very few individuals reaching pre-pupa and dying. (c) Larval viability of the 
UAS-Twinkle A442P lines was measured as the mean ratio between the number of wild-type pupae and the total 
number of pupae per vial (+/− standard deviation), originated from crosses using UAS-Twinkle A442P / TM6B-
Tubby and daGAL4 (induced) or w1118 (uninduced). The expected Mendelian ratio of wild-type pupae (carrying 
UAS-Twinkle A442P) for these crosses is 0.5 (dashed line). See Supplementary Fig. S1 for details of the genetic 
crosses. no AOX, mut AOX, low AOX and high AOX indicate respectively the constructs UAS-empty2nd, UAS-
mutAOX2nd, UAS-wtAOX8.1 21 and UAS-wtAOXF6 12. Letters a-d indicate significantly different statistical classes 
(P < 0.05) according to one-way ANOVA, followed by the Tukey post-hoc test, applied separately for the data in 
(a) left panel, and (c). No significant differences were found (P > 0.05) for the data shown in (a) right panel.
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mitochondrial respiration data and developmental assays using mhcGAL4 and elavGAL4 suggest that the lethality 
caused by the Twinkle variants are independent of the action of these mutants in tissues traditionally affected by 
mitochondrial disorders.
The knockdown of Twinkle is pupal lethal and cannot be rescued by AOX. To eliminate the possi-
bility that the inability of AOX to rescue our Twinkle models was because of the overexpression system, we also 
created and tested four UAS-AOX lines combined with UAS-Twinkle RNAi (see Supplementary Table S1). To 
our knowledge, this is the first report describing the use of this RNAi line from the Vienna Drosophila Research 
Center (VDRC), so we first verified its effect on the levels of Twinkle mRNA in controls (UAS-Twinkle RNAi; 
UAS-AOX X w1118) and induced individuals (UAS-Twinkle RNAi; UAS-AOX X daGAL4) to show the efficacy of 
the construct (see Supplementary Fig. S1 for crossing schemes). As expected, Twinkle mRNA was knocked down 
to 40–50% of the control levels in all lines (Supplementary Fig. S5a). Flies with low levels of Twinkle presented 
mtDNA depletion (Supplementary Fig. S5c) and reached the pupal stage, unlike most mutant overexpressors, but 
~75% of them failed to eclose. AOX did not significantly alter viability (Supplementary Fig. S5b), except when 
expressed at a high level, which once again appeared to exacerbate the lethality caused by Twinkle disturbances. 
This data demonstrates that the AOX bypass does not mitigate the effects of Twinkle defects caused either by 
overexpression of mutants or by depletion of the endogenous enzyme.
AOX is unable to rescue other mtDNA replication defects. Considering that Twinkle and pol γ 
are part of the same replication machinery, our findings contrast those of Humphrey et al.17, in which AOX 
expression in Drosophila was shown to counteract deleterious effects of pol γ (tamas) knockdown in develop-
ment (using the ubiquitous Act5CGAL4 driver) and in neurodegeneration models (using specific neural drivers). 
We therefore created and analyzed eight additional UAS-AOX lines combined with UAS-tamas RNAi or with a 
polymerase-active-site mutant of the catalytic subunit of pol γ, tamas Q1009A (see Supplementary Table S1). 
This RNAi line is the same as was used by Humphrey et al.17, whereas the tamas Q1009A mutation has been engi-
neered in its natural genomic location, presenting the same expression pattern for the gene as in a wild-type line29. 
Both models promoted distinct developmental defects (see Supplementary Figs S1 and S6 for crossing schemes): 
UAS-tamas RNAi, when induced, led to mtDNA depletion (Supplementary Fig. S5d) and ~100% lethality at the 
pupal stage (Fig. 4a), whereas tamas Q1009A individuals died as L3 larvae (Fig. 4b). Coexpression of AOX, at low 
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Figure 2. AOX does not interfere with mtDNA copy number in mutant Twinkle lines. Total DNA from larva 
and adult samples and quantitative PCR were performed as described in the Methods. Uninduced and induced 
indicate samples originated from the crosses UAS-AOX; UAS-Twinkle X w1118 and UAS-AOX; UAS-Twinkle X 
daGAL4, respectively. Relative mtDNA copy number (mtDNA/nDNA) was normalized by the mean 2−ΔΔCT of 
control samples from the crosses UAS-empty2nd; UAS-Twinkle X w1118 in every panel. no AOX, mut AOX, low 
AOX and high AOX indicate respectively the constructs UAS-empty2nd, UAS-mutAOX2nd, UAS-wtAOX8.1 21 and 
UAS-wtAOXF6 12. Letters a-d indicate significantly different statistical classes (P < 0.05) according to one-way 
ANOVA, followed by the Tukey post-hoc test, applied separately for the data in each panel.
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or high levels, had no effect on the phenotypes of these pol γ-deficient flies (Fig. 4 and Supplementary Fig. S5d), 
indicating that this alternative enzyme is in general unable to ameliorate mtDNA replication defects caused by 
disturbances in different components of the mtDNA replisome.
Discussion
It has been shown that the xenotopic expression of C. intestinalis AOX in mammalian and insect mitochondria 
is efficient in rescuing diverse models of mitochondrial dysfunction, especially those with OXPHOS complex 
IV deficiencies30,31. AOX appears to be safely expressed and to function only when the cytochrome segment 
of the RC is deficient11,12, which makes it an attractive enzyme to be used in future therapies for mitochon-
drial diseases10. Nevertheless, there are aspects of AOX expression in heterologous systems that warrant further 
evaluation, such as the effects of its thermogenic and antioxidant properties. Heat production by mitochondrial 
uncoupling is to date only detectable in AOX-expressing cells in the presence of antimycin A32, but the lowering 
of ROS apparently occurs even under normal physiological conditions when OXPHOS is properly functioning, 
at least in adult flies33. In addition, the fact that AOX can rescue developmental defects not related, a priori, to 
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Figure 3. Mitochondrial respiration is not affected by overexpression of Twinkle nor AOX. Oxygen 
consumption was measured as described in the Methods in samples expressing the indicated AOX and Twinkle 
variants (UAS-AOX; UAS-Twinkle X daGAL4). Respiration linked to complex I substrate oxidation (upper 
panel) was calculated as the mean oxygen consumption after addition of pyruvate, proline, malate and ADP, 
followed by inhibition with antimycin A and rotenone. AOX activity (antimycin A-resistant respiration) was 
calculated as the mean oxygen consumption after addition of pyruvate, proline, malate, ADP and antimycin 
A, followed by inhibition with propyl-gallate and rotenone. Complex IV activity was calculated as the mean 
oxygen consumption after addition of TMPD and ascorbate, followed by inhibition with potassium cyanide. no 
AOX, mut AOX, low AOX and high AOX indicate respectively the constructs UAS-empty2nd, UAS-mutAOX2nd, 
UAS-wtAOX8.1 21 and UAS-wtAOXF6 12. No significant differences were found (P > 0.05) according to one-way 
ANOVA, followed by the Tukey post-hoc test.
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mitochondrial dysfunction, such as cleft thorax, notched wings, leg malformations, and bristle abnormalities in 
Drosophila20, indicates that yet unknown cellular mechanism(s) is(are) operating when AOX is present in the 
mitochondria of higher animals.
At the other end of the spectrum of AOX applicability, there is a reported case of a true mitochondrial dysfunc-
tion, whose associated phenotypes were not ameliorated by the transgenic expression of this alternative enzyme, 
namely flies bearing the tko25t mutation34. This mutant has a defective mitochondrial ribosomal protein S12, 
impairing organellar protein synthesis and causing developmental delay and neurological problems35. Because 
another alternative enzyme, the alternative NADH dehydrogenase Ndi1, was also unable to rescue tko25t, the 
authors concluded that this mutant has a more complex metabolic defect, e.g. affecting multiple RC components, 
or some other process34. Here, we describe another case of AOX inability to rescue mitochondrial dysfunction in 
Drosophila. Overexpression of Twinkle mutants or knockdown of the endogenous enzyme caused developmental 
lethality at different stages with varying levels of mtDNA depletion, which was not alleviated by AOX. AOX was 
also unable to rescue the lethality caused by expression of a catalytically inactive pol γ or knockdown of its cata-
lytic subunit, nor any of the molecular and biochemical parameters associated with mutant Twinkle expression. 
At high levels, AOX was in fact more detrimental for flies with Twinkle defects. One possible explanation is that 
the mutant Twinkle, or the depletion of the wild-type enzyme, in some way affects the organization of the inner 
mitochondrial membrane, and the further expression of a membrane-targeted protein (active or inactive AOX) 
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Figure 4. AOX does not rescue the developmental defects caused by genetic disturbances of pol γ. (a) 
Transcript levels of tamas, the coding gene for the catalytic subunit of pol γ (left panel), were measured as 
described in the Methods. Pupal viability (right panel) was measured as the mean ratio between the number of 
adults eclosed and the number of pupae per vial (+/− standard deviation). Uninduced and induced indicate 
samples originated from the crosses UAS-tamas RNAi; UAS-AOX X w1118 and UAS-tamas RNAi; UAS-AOX X 
daGAL4, respectively. (b) Viability of the tamas Q1009A lines was measured as the mean ratio between the 
number of wild-type adults and the total number of individuals per vial (+/− standard deviation). Left panel, 
progeny originated from crosses using tamas Q1009A/CyO; UAS-AOX and w1118 (uninduced) or daGAL4 
(induced) to generate a heterozygous tamas Q1009A progeny, serving as controls. The expected Mendelian 
ratio of wild-type adults (carrying one tamas Q1009A allele) for these crosses is 0.5 (dashed line). Right panel, 
progeny originated from crosses using tamas Q1009A/CyO; UAS-AOX and tamas Q1009A/CyO (uninduced) 
or tamas Q1009A/CyO; daGAL4 (induced) to generate a homozygous tamas Q1009A progeny. The expected 
Mendelian ratio of wild-type adults (carrying two tamas Q1009A alleles) for these crosses is zero, as tamas 
Q1009A in homozygozity is lethal29. See Supplementary Fig. S6 for details of the genetic crosses. no AOX, 
mut AOX, low AOX and high AOX indicate respectively the constructs UAS-empty3rd, UAS-mutAOX3rd, UAS-
wtAOX7.1 21 and UAS-wtAOXF24 12. *indicates statistical differences (P < 0.05) according to Student’s t-tests. 
Letters a-b indicate significantly different statistical classes (P < 0.05) according to one-way ANOVA, followed 
by the Tukey post-hoc test, applied separately for the data in (a) right panel, and (b) right and left panels. No 
significant differences were found (P > 0.05) for the data shown in (b).
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synergistically impairs even more larval/pupal viability. Twinkle has been associated with a specific lipid domain 
of the inner mitochondrial membrane36,37, consistent with this hypothesis.
However, similar aggravations of developmental problems were also observed for tko25t in the presence of 
Ndi1, or Ndi1 plus AOX34. We speculate that in both cases, the metabolic consequences of severely defective 
mtDNA replication/mitochondrial translation may result in the activation of AOX, leading to an additional 
decrease in ATP production due to partial diversion of electron flow. Both the multi-subunit mitochondrial ribo-
somal machinery, of which the tko gene product is an essential part, and the modularly-architectured, multimeric 
Twinkle enzyme are dependent on the energy of nucleotide tri-phosphate hydrolysis for their proper functions in 
organellar protein synthesis and genome maintenance, respectively (reviewed in3,38). For example, the recombi-
nant human wild-type Twinkle not only requires Mg2+ and ATP for dsDNA unwinding and ssDNA translocation, 
but the enzyme also presents significantly higher stability in vitro in the presence of such compounds39. Therefore, 
fluctuations in the ATP level in a sensitive mitochondrial genetic condition, such as that found in the tko25t and 
Twinkle models, may worsen the defects caused by such mutant proteins, which may in turn require even higher 
than normal nucleotide levels to maintain their fragile stability and/or function.
One of the primary effects of disturbing Twinkle or pol γ is the decrease of intact copies of mtDNA (via rear-
rangements, nucleotide substitutions or degradation)22,29, which in turn impairs mitochondrial RNA and protein 
synthesis40. tko25t produces a defect directly in the mitochondrial translation apparatus, downstream of Twinkle 
and pol γ, although its phenotypic consequences appear less severe than those of our mtDNA replication models. 
Nonetheless, the end result is similar: incorrect or insufficient subunits of all four OXPHOS complexes partly 
encoded in mtDNA, which AOX cannot circumvent. The fact that the mitochondrial genome encodes seven sub-
units of OXPHOS complex I and two subunits of complex V (~70% of all mtDNA genes) may explain the inability 
of AOX to rescue mitochondrial gene expression defects, as this enzyme is predicted to counteract complexes III 
and/or IV deficiencies.
Although in accord with the above hypothesis, our data appears inconsistent with the previously published 
findings showing significant improvement in the phenotypes associated with the knockdown of pol γ in diverse 
cell types of Drosophila17. We speculate that differences in the genetic background of the fly lines, in dietary 
conditions, and in experimental design might explain these discrepancies. Even though conditions appear to be 
homogenous within each study, they are difficult to compare side-by-side. Our implementation of two controls 
(for promoter dilution and for AOX enzymatic activity), plus two expression levels for AOX, and two defective pol 
γ models (knockdown and mutant expression), does represent a robust experimental design. On the other hand, 
the use by Humphrey et al.17 of several neural-specific GAL4 drivers does make their report reliable regarding 
pol γ depletion in the nervous system. Deficiencies of RC complex III and/or IV in specific neuronal classes are 
thus implied to underlie neurodegeneration in pol γ disease, in contrast to the broader effects of mtDNA rep-
lication defects documented in our study. Another important difference is that the drivers used for ubiquitous 
knockdown are different: daGAL4, used here, and Act5CGAL4 used by Humphrey et al.17 may differ in their exact 
strength, tissue and stage-specificity, and response to conditions. Notably, in combination with daGAL4, we found 
UAS-tamas RNAi to be pupal lethal, whereas in combination with Act5CGAL4, Humphrey et al.17 found it to be 
only semilethal, with AOX impacting the number of progeny. Clearly, the matter needs further investigation.
Our combined biochemical and genetic data also revealed an unexpected phenomenon regarding the over-
expression of Twinkle variants in Drosophila: the absence of OXPHOS defects in larval body-wall mitochondria 
despite severe mtDNA depletion in whole L3 larval homogenates, as well as the absence of developmental lethal-
ity in the case of tissue-specific expression of mutant Twinkle in muscle and neurons. Maternal protein, RNA 
and even mtDNA may supply enough mitochondrial activity in those tissues to complete development. Because 
the large storage of triglycerides in the L3 larvae could interfere with the respiration measurements, we used 
a previously validated protocol29 in which the animals were dissected to eliminate all internal organs and the 
hemolymph, preserving the larval body wall (comprising muscle, nerve and epidermis) for these experiments. 
The results imply either that the larval phenotype described by us and others22 upon mutant Twinkle overex-
pression is caused by effects in one or more of these internal organs, or else could be due to an additional but 
unknown biological role of Twinkle, separate from mtDNA maintenance. The findings suggest a crucial role for 
mitochondria in the brain, fat body or other tissues that generate and respond to signals governing metamorpho-
sis, over which AOX has no influence. Future studies using other tissue-restricted drivers for the larva, including 
ring gland, fat body, Malpighian tubule, salivary gland, glia, neuroendocrine cells, among others, will help us 
understand these roles.
As the human diseases associated with Twinkle and pol γ mutations account for a significant portion of all 
mitochondrial disorders, AOX may have limited applicability in therapy. Indeed, taking into account the com-
bined data on tko25t, Twinkle and pol γ, we would argue that consideration of the possible use of AOX in therapy 
should exclude deficiencies in mtDNA maintenance or gene expression, unless clear benefits can be robustly 
demonstrated in a specific, clinically relevant model.
Methods
Fly stocks and maintenance. The standard line w1118, balancer lines CyO, TM3,Sb and TM6B-Tubby, 
and driver lines daughterless-GAL4 (daGAL4), myosin heavy chain-GAL4 (mhcGAL4) and embryonic lethal 
abnormal visionC155-GAL4 (elavGAL4) were obtained from stock centers. The lines UAS-AOXF6, UAS-AOXF24 12, 
UAS-wtAOX8.1, UAS-wtAOX7.1, UAS-empty2nd, UAS-empty3rd, UAS-mutAOX2nd and UAS-mutAOX3rd 21 were used 
in genetic crosses with the balancers described above to establish double transgenic lines in combination with 
UAS-Twinkle WT, UAS-Twinkle K388A, UAS-Twinkle A442P22, UAS-Twinkle RNAi (VDRC ID 108644/KK), UAS-
tamas RNAi (VDRC ID 106955/KK) and tamas Q1009A29. Supplementary Table S1 shows the genotypes of all 
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lines created for this work. All fly lines were first backcrossed into the w1118 background for six-to-ten generations, 
and were maintained in standard diet12 at 18 or 25 °C, with 12 hr light/dark cycles.
Developmental assays. 10–15 virgin adult females of the indicated genotypes (Supplementary Table S1) 
were crossed with 5–7 adult control (w1118) or GAL4-expressing males (daGAL4 or mhcGAL4) per vial, and 
allowed to lay eggs for 24 hrs at 25 °C in standard diet12, where the offspring were kept until eclosion (see 
Supplementary Figs S1 and S5 for crossing schemes). For the neuron-specific transgene expression, elavGAL4 
females were crossed with UAS construct-bearing males. The offspring of the UAS-Twinkle RNAi lines were kept 
at 29 °C to enhance the knockdown and its associated phenotype. Development was analyzed visually at the larval 
stage and quantitatively at the pupal stage, as the mean ratio between the number of eclosed adults and the num-
ber of pupae per vial, for a total of 8 vials per experiment, with 3 biological replicates.
Immunoblotting. Protein extracts from 10 whole 1-to-3-day-old adult males of the indicated genotype were 
prepared by gentle grinding of tissues in 200 μl PBS containing 1.5% Triton X-100 on ice. The suspension was 
centrifuged at 16,000 gmax for 10 min at 4 °C, and protein concentration of the supernatant was measured by the 
Bradford method. 100 μg of total protein extracts were mixed with 5X Laemmli buffer (10% SDS, 50% glycerol, 
25% 2-mercaptoethanol, 0.02% bromophenol blue and 0.3125 M Tris-HCl, pH 6.8), denatured at 95 °C for 5 min 
and resolved by SDS-PAGE on 12% polyacrylamide gels at 120 V for approximately 1.5 h. Proteins were trans-
ferred to nitrocellulose membranes using the semi-dry gel transfer system MSD10 (Major Science, USA) for 
15 min at room temperature. Membranes were blocked in PBST (8 mM Na2HPO4, 2 mM KH2PO4, 150 mM NaCl, 
30 mM KCl, 0.05% Tween 20, pH 7.4) containing 5% dried nonfat milk for 2 h at room temperature or over-
night at 4 °C. Primary antibodies [rabbit polyclonal anti-AOX12 (1:10,000), rabbit polyclonal anti-Dmhelicase25 
(1:4,000), and mouse monoclonal anti-PDH E1α (1:5,000, Abcam, UK)] were incubated for at least 1 h at room 
temperature, followed by three washes (10 min each) with PBST. Secondary antibodies [HRP-conjugated goat 
anti-rabbit and anti-mouse IgGs (1:10,000, Bio-Rad, USA)] were incubated for at least 2 h at room temperature, 
and washed as described above. Membranes were incubated in Luminol substrate detection system Immun-Star 
HRP (Bio-Rad, USA), and chemiluminescence signals were detected on a ChemiDoc Imaging System (Bio-Rad, 
USA).
Nucleic acid isolation and quantitative PCR. Total DNA was extracted as described previously24, using 
5–10 L3 larvae (5 days after egg laying) or adult males (1–3 days after eclosion) per preparation. To estimate rela-
tive mtDNA copy number, 15 ng of total DNA were used as template in a 20 μl quantitative PCR reaction, contain-
ing 10 μl PowerUp SYBR Green Master MixTM (Thermo Fisher Scientific) and 10 μM of each primer. The primers 
used were 16S-R (5′-TCGTCCAACCATTCATTCCA-3′) and 16S-L (5′-TGGCCGCAGTATTTTGACTG-3′) to 
amplify the mitochondrial 16S rRNA gene, and RpL32F (5′-AGGCCCAAGATCGTGAAGAA-3′) and RpL32A 
(5′-TGTGCACCAGGAACTTCTTGAA-3′) to amplify the single-copy, nuclear RpL32 gene. Reactions were per-
formed in a StepOnePlusTM Real-Time PCR instrument (Applied Biosystems), under the manufacturer’s recom-
mended conditions: 95 °C for 2 min, followed by 40 cycles of 95 °C for 3 s and 60 °C for 30 s. The ΔΔCT values 
were calculated by comparing the ratios between the mitochondrial and nuclear target genes. The relative mtDNA 
copy number values were derived by comparing each group of UAS-AOX; UAS-Twinkle lines to the same control 
sample (UAS-empty2nd; UAS-Twinkle X w1118) that was arbitrarily given the value 1.0.
Total RNA was prepared from 5 larvae using the TRIzol® plus PureLink RNA Mini Kit, and was reverse- 
transcribed using the SuperScript™ IV VILO™ Master Mix with ezDNase™ Enzyme kit (Thermo Fisher 
Scientific), according to the manufacturer’s recommendations. The quantitative PCR reactions to estimate 
the relative amounts of mtDNA-helicase (Twinkle) and tamas transcripts were performed essentially as 
described above, except that 1 μl of a 1:25 dilution of the reverse transcription reaction was used as template, 
along with 10 μM of the specific primers: TwinkleF (5′CCAAAGCGGTTCTAGTCAGC3′) and TwinkleR 
(5′GACTGGCATCGTAGTGCAAC3′) for mtDNA-helicase; tamasF (5′AAAATGTTCTCCATCACAAAGG3′) 
and tamasR (5′TTGGGACGATGAAATACCTC3′) for tamas; and RpL32F and RpL32A (described above) for 
RpL32. The relative transcript values were derived from the standard curve method, by comparing the ratio 
between mtDNA helicase and RpL32, or tamas and RpL32 for each UAS-RNAi; UAS-AOX X daGAL4 line to its 
control sample (UAS-RNAi; UAS-AOX X w1118) that was arbitrarily given the value 1.0.
Mitochondrial oxygen consumption. Five L3 larvae (5 days after egg laying) of the indicated gen-
otype were dissected as previously29 in ice-cold PBS, eliminating the internal organs and the hemolymph, to 
obtain the larval body wall, which was then weighed in an analytical balance, gently homogenized in isolation 
buffer (250 mM sucrose, 5 mM Tris-HCl, 2 mM EGTA, 1% BSA, pH 7.4), and transferred to the oxygraph O2k 
chambers (Oroboros, Inc.). Oxygen consumption was measured at 25 °C in assay buffer (120 mM KCl, 0.5 mM 
KH2PO4, 3 mM HEPES, 1 mM EGTA, 1 mM MgCl2, 1% BSA, pH 7.2) after addition of substrates for com-
plex I (5 mM sodium pyruvate, 5 mM L-proline and 1.5 mM malate), and complex IV (1.9 mM N,N,N′,N′-tet
ramethyl-p-phenylenediamine [TMPD] and 4 mM ascorbate) in the presence of 1 mM ADP. Complex I- and 
IV-driven respiration was corrected for the signal obtained after addition of 50 nM antimycin A and 5 nM rote-
none, and 100 nM potassium cyanide, respectively. The antimycin A-resistant complex I-driven oxygen consump-
tion, corrected for the signal obtained after addition of 200 nM propyl-galate and 5 nM rotenone, was attributed 
to AOX.
Statistical analyses. Statistical differences among the indicated groups of flies were tested using one-way 
ANOVA with Tukey post hoc test, as indicated in the figure legends, except for differences in Twinkle and tamas 
transcript levels, for which Student t-tests were applied. The analyses were performed using the software SAS 
University Edition v9.4 (SAS Institute Inc.).
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Data Availability Statement. Any material or fly line used in this work is available from the corresponding 
author upon individual requests at any moment.
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